<DOC>
	<DOCNO>NCT00241319</DOCNO>
	<brief_summary>The purpose study establish efficacy R89674 0.25 % ophthalmic solution compare placebo alleviate sign symptom conjunctival allergen challenge-induced allergic conjunctivitis</brief_summary>
	<brief_title>Evaluation Efficacy Ophthalmic Solution Induced Acute Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>history ocular allergy positive skin test reaction cat hair , cat dander , grass , ragweed , and/or tree within past 24 month ; calculate bestcorrected visual acuity 0.6 logMar good eye ; positive bilateral conjunctival allergy challenge reaction narrow angle glaucoma , clinically significant blepharitis , follicular conjunctivitis , iritis pterygium diagnosis dry eye ocular surgical intervention within 3 month history refractive surgery within 6 month know history retinal detachment , diabetic retinopathy , progressive retinal disease presence active ocular infection positive history ocular herpetic infection preauricular lymphadenopath manifest sign symptom clinically active allergic conjunctivitis</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>ocular , allergic conjunctivitis , ophthalmic</keyword>
</DOC>